Skip to content
Medical Health Aged Care

GPs applaud SA lung cancer screening investment: ‘It’s a conversation that can save a life’

Royal Australian College of GPs 2 mins read

The Royal Australian College of GPs (RACGP) has applauded a $3 million investment by the South Australian Government to support lung cancer screening and treatment in the state.

The SA investment builds on the National Lung Cancer Screening Program, which commenced in July, and aims to deliver more lung cancer assessment and treatment programs across Adelaide so patients diagnosed in the program can quickly access follow-up assessments and care.

The national program provides free lung cancer screening for high-risk patients, in line with the RACGP’s Red Book preventive health recommendations for the disease.

To be eligible, patients must:

  • be aged 50–70 years
  • be asymptomatic, with no signs or symptoms suggesting lung cancer
  • currently smoke or have quit smoking in the past 10 years
  • have a history of tobacco cigarette smoking of at least 30 ‘pack years’, which is calculated by multiplying the number of cigarette packs smoked per day by the number of years the person has smoked.

RACGP SA Chair Dr Siân Goodson urged smokers and former smokers to book an appointment with their GP.

“Everyone knows smoking harms you and can cause cancer,” she said.

“This screening program means you can find out early and for free if your lungs have been affected by smoking. And more importantly, you can take action, so you live a longer and healthier life.

“We hope this $3 million investment by the Malinauskas Government will make that follow up testing and treatment for lung cancer more accessible to more people in South Australia and helps patients diagnosed with lung cancer in the screening program access care earlier.

“I’m urging everyone in SA who smokes or previously smoked to book a consultation with your usual GP.

“If you meet the criteria, we can organise your first low-dose CT scan screening, which can be repeated every two years. Spotting lung cancer early makes an enormous difference.

“If you’re a younger smoker, we can talk about medications, counselling, and other treatments that are backed by evidence and the experience of former smokers. We can help you take back control from tobacco.

“Nicotine’s addictive. That takes choice away from you. Your GP can give you non-judgemental opportunities to take that choice back.

“Speak to your GP. It’s a conversation that can save your life.”

~ENDS


About us:

The Royal Australian College of General Practitioners (RACGP) is the peak representative organisation for general practice, the backbone of Australia’s health system. We set the standards for general practice, facilitate lifelong learning for GPs, connect the general practice community, and advocate for better health and wellbeing for all Australians.

Visit www.racgp.org.au. To unsubscribe from RACGP media releases, click here.


Contact details:

John Ronan
Senior Media Advisor

Stuart Winthrope
Media Advisor

Kevin Diggerson
Public Affairs Manager

Contact: 03 8699 0992[email protected]

Follow us on X and Facebook.

Media

More from this category

  • Medical Health Aged Care
  • 22/01/2026
  • 23:11
Concept Medical Inc.

Concept Medical Announces First Patient Enrollment in STARS DAPT Randomized Clinical Trial Evaluating Abluminus NP Polymer-Free DES

TAMPA, Fla.–BUSINESS WIRE– Concept Medical Inc., a global pioneer in innovative drug delivery technology, is proud to announce the successful enrollment of the first…

  • Contains:
  • Medical Health Aged Care
  • 22/01/2026
  • 22:11
Sinovac Biotech Ltd.

SINOVAC Announces Nasdaq Hearings Panel Grants Continued Listing

BEIJING--BUSINESS WIRE-- Sinovac Biotech Ltd. (Nasdaq: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that the Nasdaq Hearings Panel (the “Panel”) has granted the Company’s request to continue its listing on the Nasdaq Stock Market, subject to stated conditions focused on timely completion of its financial audit and remediation of filing delinquencies. Under the Panel’s decision, SINOVAC must, on or before May 11, 2026, demonstrate compliance with Nasdaq Listing Rule 5250(c)(1) and Listing Rule 5250(c)(2) by completing filings of its annual report for the year ended December 31, 2024 on Form 20-F and…

  • Medical Health Aged Care
  • 22/01/2026
  • 17:11
Galderma

IMCAS 2026: Galderma Showcases the Latest Scientific Advances Behind the Industry’s Broadest Injectable Aesthetics Portfolio

At IMCAS 2026, Galderma will present findings supporting Sculptra’s® regenerative properties and benefits on the body, including improving cellulite appearance, firmness, lift, projection, and…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.